γ-羟丁酸过量患者气管插管的指征与并发症:单中心毒理学单元回顾性分析
该研究回顾性分析了2000年1月至2024年12月单中心毒理学单元的γ-羟丁酸过量病例。159例就诊中37例(23%)需气管插管。插管指征以呕吐和气道保护不足风险为主,但插管并未完全防止吸入性肺炎,11例(30%)确诊吸入性肺炎,包括呕吐11例中6例、喉梗阻5例中3例、为气道保护插管14例中2例。作者认为单用格拉斯哥昏迷评分评估毒理学就诊者的气道风险可能导致不必要干预并增加并发症,需更好识别需气道干预的患者并制定降低误吸风险的策略。
要点
- 159例γ-羟丁酸过量就诊中37例(23%)需气管插管,呕吐和气道保护不足风险是主要插管指征。
- 插管患者中11例(30%)确诊吸入性肺炎:呕吐者11例中6例、喉梗阻5例中3例、为气道保护插管14例中2例。
- 插管并未完全防止吸入性肺炎,作者认为单用格拉斯哥昏迷评分评估气道风险可能导致不必要干预并增加并发症。
- 作者指出需更好识别需气道干预的患者,并制定降低γ-羟丁酸过量患者误吸风险的策略。
适用人群与场景
- 2000年1月至2024年12月单中心毒理学单元收治的γ-羟丁酸过量就诊者,共159例就诊。
红旗征与不能漏的情况
- 呕吐:11例呕吐插管患者中6例确诊吸入性肺炎。
- 喉梗阻:5例因喉梗阻插管患者中3例确诊吸入性肺炎。
研究设计与关键结果
- 研究类型:单中心回顾性综述,时间范围2000年1月至2024年12月,共159例γ-羟丁酸过量就诊。
- 37例患者(23%)需要气管插管。
- 吸入性肺炎确诊11例(30%),包括呕吐11例中6例、喉梗阻5例中3例、为气道保护插管14例中2例。
- 呕吐和气道保护不足风险是γ-羟丁酸过量气管插管的主要指征,插管并未完全防止吸入性肺炎。
证据类型、等级与局限
- 证据类型:单中心回顾性综述。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,单用格拉斯哥昏迷评分评估毒理学就诊者的气道风险可能导致不必要干预并可能增加并发症。
- 作者指出需更好识别需气道干预的患者,并制定降低γ-羟丁酸过量患者误吸风险的策略。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Gamma-hydroxybutyrate is a central nervous system depressant that can lead to a severely reduced level of consciousness, necessitating endotracheal intubation and intensive care admission. This study aims to analyse the clinical reasoning for endotracheal intubation in gamma-hydroxybutyrate overdoses, the incidence of complications, and length of stay.
METHOD: We conducted a retrospective review of gamma-hydroxybutyrate overdoses between January 2000 and December 2024 in a single toxicology centre. Data collected included demographics, reason for endotracheal intubation, presence of aspiration pneumonitis, and length of stay.
RESULTS: There were 159 gamma-hydroxybutyrate presentations and 37 patients (23%) required endotracheal intubation. Aspiration pneumonitis was confirmed in 11 patients (30%), including six of eleven with vomiting, three of five with laryngeal obstruction and two of fourteen intubated for airway protection.
DISCUSSION: Vomiting and a perceived risk of inadequate airway protection were the main indications for endotracheal intubation in gamma-hydroxybutyrate overdose, which did not entirely prevent aspiration pneumonitis. Use of the Glasgow Coma Scale alone for airway risk assessment in toxicology presentations may result in unnecessary intervention and may increase complications.
CONCLUSION: These data highlight the need to better identify patients requiring airway intervention and develop strategies to reduce aspiration risk in patients with gamma-hydroxybutyrate overdose.
参考来源
- Berling I, Downes MA, McArdle K, et al. Indications for and complications of endotracheal intubation in gamma-hydroxybutyrate (GHB) overdoses admitted to a toxicology unit. Clin Toxicol (Phila). 2025. PMID: 40396669. doi:10.1080/15563650.2025.2503442
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。